HPQ
57
-2
FDX
40
4
XRX
41
6
PNR
69
4
DOW
34
4
FRT
45
6
WDC
43
2
XEL
69
2
O
22
2
GILD
49
2
VTR
54
5
WAT
53
6
HSIC
51
-3
RL
68
3
PBI
65
5
CVX
44
-2
DD
60
4
MTCH
42
5
ROP
59
5
DTE
54
4
HPQ
57
-2
FDX
40
4
XRX
41
6
PNR
69
4
DOW
34
4
FRT
45
6
WDC
43
2
XEL
69
2
O
22
2
GILD
49
2
VTR
54
5
WAT
53
6
HSIC
51
-3
RL
68
3
PBI
65
5
CVX
44
-2
DD
60
4
MTCH
42
5
ROP
59
5
DTE
54
4
Financhill
Back

Travere Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

TVTX
Travere Therapeutics

Last Price:
18.2700
Seasonality Move:
13.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Travere Therapeutics Price Quote

$18.2700
+0.0100 (+0.05%)
(Updated: November 22, 2024 at 5:55 PM ET)

Travere Therapeutics Key Stats

Sell
42
Travere Therapeutics (TVTX) is a Sell
Day range:
$17.8900 - $18.6400
52-week range:
$5.1200 - $20.3300
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.93
P/B ratio:
0%
Volume:
903.6K
Avg. volume:
1.4M
1-year change:
223.19%
Market cap:
$1.4B
Revenue:
$145.2M
EPS:
$-4.55

How Much Does Travere Therapeutics Make?

Is Travere Therapeutics Growing As A Company?

  • What Is Travere Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.7%
  • What Is Travere Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Travere Therapeutics Stock Price Performance

What Is Travere Therapeutics 52-Week High & Low?

Travere Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Travere Therapeutics?

Is Travere Therapeutics Cash Flow Positive?

  • What Is TVTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$272.2M
  • What Is Travere Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $427K
  • What Is Travere Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $162.7M

Travere Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TVTX return on invested capital is -72.38%
  • What Is Travere Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -52.6%
  • What Is TVTX Return On Equity?
    ROE is a measure of profitability and is -325.82%

Travere Therapeutics Earnings Date & Stock Price

Travere Therapeutics Competitors

Travere Therapeutics Dividend Yield

Travere Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.26%
Revenue: 69.56% 3.4%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 26.9375
Upside from Last Price: 47.52%

Major Shareholders

  • How many TVTX shares are owned by institutional investors?
    126.2M TVTX shares are owned by institutional investors
  • How many TVTX shares are owned by insiders?
    4M TVTX shares are owned by insiders